Intermittent Fasting Shows Promise in Slowing Huntington's Disease Progression
Summary
Research from Oregon Health & Science University reveals that intermittent fasting may offer a promising new therapeutic approach for Huntington's disease, a progressive neurodegenerative disorder. The study demonstrates that modifying eating patterns could help slow disease progression, providing hope for patients with this inherited genetic condition. Huntington's disease affects the brain's ability to control movement, emotions, and cognition, making new treatment options critically important. This dietary intervention represents a non-pharmaceutical strategy that could complement existing treatments and improve quality of life for affected individuals.
